The quickly evolving major presence of Artificial Intelligence in healthcare means the current regulatory landscape is changing. AI-based medical devices are rapidly revolutionising the industry across the globe, but along with the many positive developments made in healthcare delivery, calls for more regulatory oversight are growing. Many countries...
READ MOREEffective regulatory systems are an essential component of health system strengthening and contribute to better public health outcomes, even more so in the age of medical devices that are enabled by machine learning. Key Points Without medical devices, many critical healthcare procedures would not be possible. WHO provides guidance...
READ MOREDigital and AI-driven technologies tangibly improve the effectiveness of healthcare delivery and access – whether holistic patient management, clinical productivity, or hospital site utilisation all of which ultimately improves patient outcomes. Yet the sector faces financial challenges to acquire the clinical, care, collaboration and buildings technology...
READ MOREDiscover why dental support organisations must go digital and how they can do so. Four guiding principles can help DSOs select and implement digital initiatives that result in optimised efficiencies, consistent treatment outcomes, and an improved experience for both patients and providers that fuels the stability and growth of organisations....
READ MOREThe article explores the potential of AI coupled with digital innovation as it pertains to future healthcare procurement. The importance of interoperability and qualification for the Virtual Company Dossier, and the potential benefits of cross-border procurement and digital platforms are discussed in detail. The article also highlights the need...
READ MOREMedical digital algorithms are computer programs that use complex mathematical equations to analyse data and make predictions about medical conditions. These algorithms have the potential to revolutionise healthcare by improving accuracy, reducing costs, and providing personalised treatment plans. Despite their potential benefits to...
READ MOREMolecular radionuclide imaging and therapies have a central role in the management of some oncological diseases, in particular they find a central application in neuroendocrine tumours (NETs). Peptide receptor imaging is a fundamental part of the tumour staging, preoperative imaging, therapy selection and restaging. Using the same drug, labelled...
READ MOREArtificial Intelligence in radiology is growing at a rapid pace. Alessandro Roncacci, SVP and CMO of Affidea, and Stéphane Maquaire, GM for Europe at Incepto Medical, reveal the dynamic partnership in Portugal, bringing to the national level the benefits and added value of AI solutions. What is the current landscape...
READ MOREThe article emphasises the importance of Business Continuity Management (BCM) in medical technology to ensure uninterrupted healthcare services. It discusses the need for BCM, challenges in implementation, benefits, and best practices. The focus is on identifying potential disruptions, developing response plans, and maintaining effective communication....
READ MOREThe COVID-19 pandemic and the rapid evolution of events on a national and international scale required the adoption of immediate and effective measures to deal with these events . Key Points The rapid responsiveness of Public Procurement Units to the pandemic. The need for public-private partnerships is illustrated. The importance...
READ MORE